| In vitro assembly of cubic RNA-based scaffolds designed in silico KA Afonin, E Bindewald, AJ Yaghoubian, N Voss, E Jacovetty, BA Shapiro, ... Nature nanotechnology 5 (9), 676-682, 2010 | 409 | 2010 |
| Self-assembling RNA nanorings based on RNAI/II inverse kissing complexes WW Grabow, P Zakrevsky, KA Afonin, A Chworos, BA Shapiro, L Jaeger Therapeutic RNA Nanotechnology, 67-93, 2021 | 276 | 2021 |
| To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives D Shi, D Beasock, A Fessler, J Szebeni, JY Ljubimova, KA Afonin, ... Advanced drug delivery reviews 180, 114079, 2022 | 242 | 2022 |
| Multifunctional RNA nanoparticles KA Afonin, M Viard, AY Koyfman, AN Martins, WK Kasprzak, M Panigaj, ... Nano letters 14 (10), 5662-5671, 2014 | 233 | 2014 |
| Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine KA Afonin, WW Grabow, FM Walker, E Bindewald, MA Dobrovolskaia, ... Therapeutic RNA Nanotechnology, 249-284, 2021 | 221 | 2021 |
| Co-transcriptional assembly of chemically modified RNA nanoparticles functionalized with siRNAs KA Afonin, M Kireeva, WW Grabow, M Kashlev, L Jaeger, BA Shapiro Nano letters 12 (10), 5192-5195, 2012 | 154 | 2012 |
| Activation of different split functionalities on re-association of RNA–DNA hybrids KA Afonin, M Viard, AN Martins, SJ Lockett, AE Maciag, EO Freed, ... Therapeutic RNA Nanotechnology, 627-650, 2021 | 138 | 2021 |
| Structure and composition define immunorecognition of nucleic acid nanoparticles E Hong, JR Halman, AB Shah, EF Khisamutdinov, MA Dobrovolskaia, ... Therapeutic RNA Nanotechnology, 911-942, 2021 | 133 | 2021 |
| Triggering of RNA Interference with RNA–RNA, RNA–DNA, and DNA–RNA Nanoparticles KA Afonin, M Viard, I Kagiampakis, CL Case, MA Dobrovolskaia, ... ACS nano 9 (1), 251-259, 2015 | 132 | 2015 |
| Aptamers as modular components of therapeutic nucleic acid nanotechnology M Panigaj, MB Johnson, W Ke, J McMillan, EA Goncharova, M Chandler, ... Therapeutic RNA Nanotechnology, 825-882, 2021 | 120 | 2021 |
| In Silico Design and Enzymatic Synthesis of Functional RNA Nanoparticles KA Afonin, WK Kasprzak, E Bindewald, M Kireeva, M Viard, M Kashlev, ... Accounts of chemical research 47 (6), 1731-1741, 2014 | 105 | 2014 |
| Functionally-interdependent shape-switching nanoparticles with controllable properties JR Halman, E Satterwhite, B Roark, M Chandler, M Viard, A Ivanina, ... Nucleic acids research 45 (4), 2210-2220, 2017 | 104 | 2017 |
| Multistrand RNA secondary structure prediction and nanostructure design including pseudoknots E Bindewald, K Afonin, L Jaeger, BA Shapiro Therapeutic RNA Nanotechnology, 95-120, 2021 | 97 | 2021 |
| Specific RNA self-assembly with minimal paranemic motifs KA Afonin, DJ Cieply, NB Leontis Journal of the American Chemical Society 130 (1), 93-102, 2008 | 92 | 2008 |
| Opportunities, barriers, and a strategy for overcoming translational challenges to therapeutic nucleic acid nanotechnology KA Afonin, MA Dobrovolskaia, G Church, M Bathe Therapeutic RNA Nanotechnology, 605-623, 2021 | 81 | 2021 |
| RNA–DNA fibers and polygons with controlled immunorecognition activate RNAi, FRET and transcriptional regulation of NF-κB in human cells W Ke, E Hong, RF Saito, MC Rangel, J Wang, M Viard, M Richardson, ... Nucleic acids research 47 (3), 1350-1361, 2019 | 80 | 2019 |
| Computational and experimental characterization of RNA cubic nanoscaffolds KA Afonin, W Kasprzak, E Bindewald, PS Puppala, AR Diehl, KT Hall, ... Therapeutic RNA Nanotechnology, 121-149, 2021 | 76 | 2021 |
| RNA fibers as optimized nanoscaffolds for siRNA coordination and reduced immunological recognition L Rackley, JM Stewart, J Salotti, A Krokhotin, A Shah, JR Halman, ... Therapeutic RNA Nanotechnology, 943-969, 2021 | 72 | 2021 |
| Co-transcriptional production of RNA–DNA hybrids for simultaneous release of multiple split functionalities KA Afonin, R Desai, M Viard, ML Kireeva, E Bindewald, CL Case, ... Nucleic acids research 42 (3), 2085-2097, 2014 | 72 | 2014 |
| Programmable nucleic acid based polygons with controlled neuroimmunomodulatory properties for predictive QSAR modeling MB Johnson, JR Halman, E Satterwhite, AV Zakharov, MN Bui, K Benkato, ... Therapeutic RNA Nanotechnology, 885-909, 2021 | 70 | 2021 |
Marina DobrovolskaiaSr.Principal Scientist, Nanotechnology Characterization Lab, NCI, LBRZweryfikowany adres z mail.nih.gov
